These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 363660)

  • 21. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antifungal prophylaxis in HIV-seropositive liver transplant recipients].
    Pozo Laderas JC
    Rev Iberoam Micol; 2011; 28(4):183-90. PubMed ID: 21420504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
    Strasfeld L; Weinstock DM
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials of antifungal prophylaxis among patients undergoing surgery.
    Calandra T; Marchetti O
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S185-92. PubMed ID: 15546116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.
    Rotstein C; Bow EJ; Laverdiere M; Ioannou S; Carr D; Moghaddam N
    Clin Infect Dis; 1999 Feb; 28(2):331-40. PubMed ID: 10064252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal therapy and its use in surgical treatment.
    Perfect JR
    Surg Gynecol Obstet; 1990; 171 Suppl():41-8. PubMed ID: 2244295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
    Lortholary O; Dupont B
    Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of fungal infections in the immunocompromised host.
    Mahfouz T; Anaissie E
    Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
    Leather HL; Wingard JR
    Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Candidiasis in the field of gastroenterological surgery].
    Ueno K; Futagami F; Nakano T; Kadoya N; Nakano Y; Nagakawa T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1280-3. PubMed ID: 1944205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.